{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:22:49Z","timestamp":1787066569031,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Log odds of positive lymph nodes (LODDS) is a novel lymph node (LN) descriptor that demonstrates promising prognostic value in many tumors. However, there is limited information regarding LODDS in patients with non-small cell lung cancer (NSCLC), especially those receiving neoadjuvant therapy followed by lung surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 2059 patients with NSCLC who received neoadjuvant therapy and surgery were identified from the Surveillance, Epidemiology, and End Results (SEER) database. We used the X-tile software to calculate the LODDS cutoff value. Kaplan\u2013Meier survival analysis and receiver operating characteristic (ROC) curve analysis were performed to compare predictive values of the American Joint Committee on Cancer (AJCC) N staging descriptor and LODDS. Univariate and multivariate Cox regression and inverse probability of treatment weighting (IPTW) analyses were conducted to construct a model for predicting prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to the survival analysis, LODDS had better differentiating ability than the N staging descriptor (log-rank test,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001 vs.\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.031). The ROC curve demonstrated that the AUC of LODDS was significantly higher than that of the N staging descriptor in the 1-, 3-, and 5-year survival analyses (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Univariate and multivariate Cox regression analyses showed that LODDS was an independent risk factor for patients with NSCLC receiving neoadjuvant therapy followed by surgery both before and after IPTW (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). A clinicopathological model with LODDS, age, sex, T stage, and radiotherapy could better predict prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with the AJCC N staging descriptor, LODDS exhibited better predictive ability for patients with NSCLC receiving neoadjuvant therapy followed by surgery. A multivariate clinicopathological model with LODDS demonstrated a sound performance in predicting prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-022-09908-3","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T03:02:52Z","timestamp":1658286172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study"],"prefix":"10.1186","volume":"22","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"9908_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"9908_CR2","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR. Non-small cell lung Cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94:1623\u201340.","journal-title":"Mayo Clin Proc"},{"key":"9908_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"9908_CR4","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jtho.2018.09.017","volume":"13","author":"GM Blumenthal","year":"2018","unstructured":"Blumenthal GM, Bunn PA Jr, Chaft JE, et al. Current status and future perspectives on neoadjuvant therapy in lung Cancer. J Thorac Oncol. 2018;13:1818\u201331.","journal-title":"J Thorac Oncol"},{"key":"9908_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.soc.2016.02.010","volume":"25","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Jaklitsch MT, Bueno R. Neoadjuvant therapy in non-small cell lung Cancer. Surg Oncol Clin N Am. 2016;25:567\u201384.","journal-title":"Surg Oncol Clin N Am"},{"key":"9908_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.21037\/qims.2018.08.02","volume":"8","author":"W Lim","year":"2018","unstructured":"Lim W, Ridge CA, Nicholson AG, et al. The 8(th) lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8:709\u201318.","journal-title":"Quant Imaging Med Surg"},{"key":"9908_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jjco\/hyy142","volume":"49","author":"A Hattori","year":"2019","unstructured":"Hattori A, Takamochi K, Oh S, et al. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer. Jpn J Clin Oncol. 2019;49:3\u201311.","journal-title":"Jpn J Clin Oncol"},{"key":"9908_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5301\/tj.5000560","volume":"103","author":"B Huang","year":"2017","unstructured":"Huang B, Ni M, Chen C, et al. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy. Tumori. 2017;103:87\u201392.","journal-title":"Tumori"},{"key":"9908_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.21037\/atm.2019.11.112","volume":"7","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Shi Z, Hu L, et al. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7:738.","journal-title":"Ann Transl Med"},{"key":"9908_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11605-014-2539-8","volume":"18","author":"P Aurello","year":"2014","unstructured":"Aurello P, Petrucciani N, Nigri GR, et al. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma? J Gastrointest Surg. 2014;18:1254\u201360.","journal-title":"J Gastrointest Surg"},{"key":"9908_CR11","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.7150\/jca.26220","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Yang C, Wang W, et al. A prognostic nomogram for cervical Cancer after surgery from SEER database. J Cancer. 2018;9:3923\u20138.","journal-title":"J Cancer"},{"key":"9908_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/jso.25888","volume":"121","author":"G Ye","year":"2020","unstructured":"Ye G, Chen Z, Wang L, et al. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy. J Surg Oncol. 2020;121:1074\u201383.","journal-title":"J Surg Oncol"},{"key":"9908_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12885-021-08410-6","volume":"21","author":"S Wang","year":"2021","unstructured":"Wang S, Yu Y, Xu W, et al. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study. BMC Cancer. 2021;21:653.","journal-title":"BMC Cancer"},{"key":"9908_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.21037\/tlcr-20-193","volume":"9","author":"Y Yu","year":"2020","unstructured":"Yu Y, Zhang P, Yao R, et al. Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study. Transl Lung Cancer Res. 2020;9:1285\u2013301.","journal-title":"Transl Lung Cancer Res"},{"key":"9908_CR15","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1\u201373.","journal-title":"Ann Intern Med"},{"key":"9908_CR16","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"9908_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/biostatistics\/kxs021","volume":"14","author":"P Saha-Chaudhuri","year":"2013","unstructured":"Saha-Chaudhuri P, Heagerty PJ. Non-parametric estimation of a time-dependent predictive accuracy curve. Biostatistics. 2013;14:42\u201359.","journal-title":"Biostatistics"},{"key":"9908_CR18","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388\u2013414.","journal-title":"Stat Med"},{"key":"9908_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2016.11.053","volume":"153","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Li G, Zheng D, et al. The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma. J Thorac Cardiovasc Surg. 2017;153:702\u20139.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9908_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"9908_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1186\/s12885-018-5048-4","volume":"18","author":"C Fortea-Sanchis","year":"2018","unstructured":"Fortea-Sanchis C, Mart\u00ednez-Ramos D, Escrig-Sos J. The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems. BMC Cancer. 2018;18:1208.","journal-title":"BMC Cancer"},{"key":"9908_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtho.2016.08.127","volume":"12","author":"H Adachi","year":"2017","unstructured":"Adachi H, Sakamaki K, Nishii T, et al. Lobe-specific lymph node dissection as a standard procedure in surgery for non-small cell lung Cancer: a propensity score matching study. J Thorac Oncol. 2017;12:85\u201393.","journal-title":"J Thorac Oncol"},{"key":"9908_CR23","doi-asserted-by":"publisher","first-page":"i92","DOI":"10.1093\/ejcts\/ezaa166","volume":"58","author":"M Mun","year":"2020","unstructured":"Mun M, Nakao M, Matsuura Y, et al. Oncological outcomes after lobe-specific mediastinal lymph node dissection via multiport video-assisted thoracoscopic surgery. Eur J Cardiothorac Surg. 2020;58:i92\u2013i9.","journal-title":"Eur J Cardiothorac Surg"},{"key":"9908_CR24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1200\/JCO.2016.67.5140","volume":"35","author":"W Liang","year":"2017","unstructured":"Liang W, He J, Shen Y, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung Cancer: a population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol. 2017;35:1162\u201370.","journal-title":"J Clin Oncol"},{"key":"9908_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-020-07260-y","volume":"20","author":"AR Baqar","year":"2020","unstructured":"Baqar AR, Wilkins S, Wang W, et al. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer. BMC Cancer. 2020;20:762.","journal-title":"BMC Cancer"},{"key":"9908_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12957-018-1483-6","volume":"16","author":"S Occhionorelli","year":"2018","unstructured":"Occhionorelli S, Andreotti D, Vallese P, et al. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery. World J Surg Oncol. 2018;16:186.","journal-title":"World J Surg Oncol"},{"key":"9908_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.lungcan.2018.05.016","volume":"122","author":"W Deng","year":"2018","unstructured":"Deng W, Xu T, Wang Y, et al. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer. Lung Cancer. 2018;122:60\u20136.","journal-title":"Lung Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09908-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T03:02:55Z","timestamp":1658286175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09908-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9908"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09908-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and the Harmonized Tripartite Guideline for Good Clinical Practice from the International Conference on Harmonization. No approval by the institutional review board was sought, and no individual patient consent was required, because SEER is a public database and the data are de-identified. The authors confirm that they are accountable for all aspects of the work (if applied, including full data access, integrity of the data and the accuracy of the data analysis) in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"801"}}